UK’s NICE Recommends Against Lynparza Tablets on NHS for Advanced, Platinum-sensitive Ovarian Cancers
News
The U.K.’s National Institute of Health and Care Excellence (NICE) has decided not to recommend Lynparza (olaparib) tablets as maintenance treatment for women with relapsed ovarian cancer who respond to platinum-based chemotherapy ... Read more